288 related articles for article (PubMed ID: 25659148)
1. Identification of synaptosomal proteins binding to monomeric and oligomeric α-synuclein.
Betzer C; Movius AJ; Shi M; Gai WP; Zhang J; Jensen PH
PLoS One; 2015; 10(2):e0116473. PubMed ID: 25659148
[TBL] [Abstract][Full Text] [Related]
2. How epigallocatechin gallate binds and assembles oligomeric forms of human alpha-synuclein.
Andersen CB; Yoshimura Y; Nielsen J; Otzen DE; Mulder FAA
J Biol Chem; 2021; 296():100788. PubMed ID: 34019875
[TBL] [Abstract][Full Text] [Related]
3. Characterizing the dynamics of α-synuclein oligomers using hydrogen/deuterium exchange monitored by mass spectrometry.
Mysling S; Betzer C; Jensen PH; Jorgensen TJ
Biochemistry; 2013 Dec; 52(51):9097-103. PubMed ID: 24191706
[TBL] [Abstract][Full Text] [Related]
4. The N-terminus of α-synuclein is essential for both monomeric and oligomeric interactions with membranes.
Lorenzen N; Lemminger L; Pedersen JN; Nielsen SB; Otzen DE
FEBS Lett; 2014 Jan; 588(3):497-502. PubMed ID: 24374342
[TBL] [Abstract][Full Text] [Related]
5. Co-existence of two different α-synuclein oligomers with different core structures determined by hydrogen/deuterium exchange mass spectrometry.
Paslawski W; Mysling S; Thomsen K; Jørgensen TJ; Otzen DE
Angew Chem Int Ed Engl; 2014 Jul; 53(29):7560-3. PubMed ID: 24740651
[TBL] [Abstract][Full Text] [Related]
6. High stability and cooperative unfolding of α-synuclein oligomers.
Paslawski W; Andreasen M; Nielsen SB; Lorenzen N; Thomsen K; Kaspersen JD; Pedersen JS; Otzen DE
Biochemistry; 2014 Oct; 53(39):6252-63. PubMed ID: 25216651
[TBL] [Abstract][Full Text] [Related]
7. Low-resolution structure of a vesicle disrupting α-synuclein oligomer that accumulates during fibrillation.
Giehm L; Svergun DI; Otzen DE; Vestergaard B
Proc Natl Acad Sci U S A; 2011 Feb; 108(8):3246-51. PubMed ID: 21300904
[TBL] [Abstract][Full Text] [Related]
8. Skeletal Muscle is a Source of α-Synuclein with a Sarcolemmal Non-Lipid Raft Distribution.
Ramirez-Soto I; Ortega-Aguilar A
Cell Physiol Biochem; 2022 Aug; 56(4):382-400. PubMed ID: 36001773
[TBL] [Abstract][Full Text] [Related]
9. Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins.
Schnack C; Danzer KM; Hengerer B; Gillardon F
Neuroscience; 2008 Jul; 154(4):1450-7. PubMed ID: 18541383
[TBL] [Abstract][Full Text] [Related]
10. Potent α-Synuclein Aggregation Inhibitors, Identified by High-Throughput Screening, Mainly Target the Monomeric State.
Kurnik M; Sahin C; Andersen CB; Lorenzen N; Giehm L; Mohammad-Beigi H; Jessen CM; Pedersen JS; Christiansen G; Petersen SV; Staal R; Krishnamurthy G; Pitts K; Reinhart PH; Mulder FAA; Mente S; Hirst WD; Otzen DE
Cell Chem Biol; 2018 Nov; 25(11):1389-1402.e9. PubMed ID: 30197194
[TBL] [Abstract][Full Text] [Related]
11. The status of the terminal regions of α-synuclein in different forms of aggregates during fibrillization.
Marvian AT; Aliakbari F; Mohammad-Beigi H; Ahmadi ZA; Mehrpooyan S; Lermyte F; Nasouti M; Collingwood JF; Otzen DE; Morshedi D
Int J Biol Macromol; 2020 Jul; 155():543-550. PubMed ID: 32240735
[TBL] [Abstract][Full Text] [Related]
12. Oleuropein derivatives from olive fruit extracts reduce α-synuclein fibrillation and oligomer toxicity.
Mohammad-Beigi H; Aliakbari F; Sahin C; Lomax C; Tawfike A; Schafer NP; Amiri-Nowdijeh A; Eskandari H; Møller IM; Hosseini-Mazinani M; Christiansen G; Ward JL; Morshedi D; Otzen DE
J Biol Chem; 2019 Mar; 294(11):4215-4232. PubMed ID: 30655291
[TBL] [Abstract][Full Text] [Related]
13. Formation and Characterization of α-Synuclein Oligomers.
Paslawski W; Lorenzen N; Otzen DE
Methods Mol Biol; 2016; 1345():133-50. PubMed ID: 26453210
[TBL] [Abstract][Full Text] [Related]
14. α-Synuclein-induced synapse damage in cultured neurons is mediated by cholesterol-sensitive activation of cytoplasmic phospholipase A2.
Bate C; Williams A
Biomolecules; 2015 Mar; 5(1):178-93. PubMed ID: 25761116
[TBL] [Abstract][Full Text] [Related]
15. Platelet alpha- and gamma-synucleins in Parkinson's disease and normal control subjects.
Li QX; Campbell BC; McLean CA; Thyagarajan D; Gai WP; Kapsa RM; Beyreuther K; Masters CL; Culvenor JG
J Alzheimers Dis; 2002 Aug; 4(4):309-15. PubMed ID: 12446933
[TBL] [Abstract][Full Text] [Related]
16. alpha-Synuclein-synaptosomal membrane interactions: implications for fibrillogenesis.
Jo E; Darabie AA; Han K; Tandon A; Fraser PE; McLaurin J
Eur J Biochem; 2004 Aug; 271(15):3180-9. PubMed ID: 15265037
[TBL] [Abstract][Full Text] [Related]
17. Plasma alpha-synuclein is decreased in subjects with Parkinson's disease.
Li QX; Mok SS; Laughton KM; McLean CA; Cappai R; Masters CL; Culvenor JG; Horne MK
Exp Neurol; 2007 Apr; 204(2):583-8. PubMed ID: 17258710
[TBL] [Abstract][Full Text] [Related]
18. Lipid Peroxidation Products HNE and ONE Promote and Stabilize Alpha-Synuclein Oligomers by Chemical Modifications.
Andersen C; Grønnemose AL; Pedersen JN; Nowak JS; Christiansen G; Nielsen J; Mulder FAA; Otzen DE; Jørgensen TJD
Biochemistry; 2021 Nov; 60(47):3644-3658. PubMed ID: 34730940
[TBL] [Abstract][Full Text] [Related]
19. α-synuclein induced synapse damage is enhanced by amyloid-β1-42.
Bate C; Gentleman S; Williams A
Mol Neurodegener; 2010 Dec; 5():55. PubMed ID: 21138585
[TBL] [Abstract][Full Text] [Related]
20. Thymoquinone protects cultured hippocampal and human induced pluripotent stem cells-derived neurons against α-synuclein-induced synapse damage.
Alhebshi AH; Odawara A; Gotoh M; Suzuki I
Neurosci Lett; 2014 Jun; 570():126-31. PubMed ID: 24080376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
